Analysis of familial male breast cancer for germline mutations in CHEK2
Authors:
- Nayanta SodhaNSNayanta Sodha
- Charlotte WilsonCWCharlotte Wilson
- Sarah L. BullockSBSarah L. Bullock
- Hazel PhillimoreHPHazel Phillimore
- Richard S. HoulstonRichard S. Houlston
- Rosalind A. EelesRERosalind A. Eeles
- 1 November 2004
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 215 (2) , 187-189
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mutations in CHEK2 Associated with Prostate Cancer RiskThe American Journal of Human Genetics, 2003
- CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumoursBritish Journal of Cancer, 2002
- Increasing evidence that germline mutations inCHEK2do not cause Li-Fraumeni syndromeHuman Mutation, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- A robust method for detectingCHK2/RAD53 mutations in genomic DNAHuman Mutation, 2002
- Chk2 kinase — a busy messengerNature Reviews Molecular Cell Biology, 2001
- The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sitesGenes & Development, 2000
- BRCA2 germline mutations in male breast cancer cases and breast cancer familiesNature Genetics, 1996
- Male breast cancer and the androgen receptor geneNature Genetics, 1993
- Breast Cancer in Men: Aspects of Familial AggregationJNCI: Journal of the National Cancer Institute, 1991